Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Dec 27, 2020; 12(12): 520-533
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.520
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.520
Table 3 Clinical characteristics of 50 hepatocellular carcinoma patients, maximum dominant tumor diameter > 6 cm, according to serum gamma glutamyl transpeptidase or alpha-fetoprotein levels
| Parameters | Low GGT ≤ 104, n = 20, median (min-max) | High GGT > 104, n = 28, median (min-max) | P value | Low AFP ≤ 200, n = 36, median (min-max) | High AFP > 200, n = 14, median (min-max) | P value |
| AFP (ng/mL) | 20.1 (0.8-6388) | 45.7 (1.9-12863) | 0.818 | |||
| GGT (IU/L) | 114 (17-1396) | 106 (29-393) | 0.862 | |||
| AST (IU/L) | 76.5 (19-566) | 71 (25-313) | 0.544 | 81 (19-566) | 76 (28-245) | 0.596 |
| Total Bilirubin (mg/dl) | 1.7 (0.23-13.9) | 1.7 (0.38-13.9) | 0.660 | 1.78 (0.23-13.9) | 1.13 (0.38-11.7) | 0.270 |
| MTD (cm) | 8.5 (6.5-22) | 8.5 (6.4-24) | 0.992 | 8.5 (6.4-24) | 8.5 (6.5-22) | 0.896 |
| Microvascular invasion, n (%) | 0.04a | 0.360 | ||||
| Negative | 9 (45) | 5 (18) | 11 (31) | 4 (29) | ||
| Positive | 11 (55) | 23 (82) | 25 (69) | 10 (71) | ||
| Differentiation, n (%) | ||||||
| Well | 11 (55) | 4 (15) | 0.011a | 13 (36) | 3 (21) | 0.324 |
| Moderate | 7 (35) | 18 (64) | 19 (53) | 7 (50) | ||
| Poor | 2 (10) | 6 (21) | 4 (11) | 4 (29) | ||
| Number of nodules | ||||||
| 1 | 10 (50) | 12 (43) | 0.845 | 16 (44) | 6 (43) | 1.000 |
| > 1 | 10 (50) | 16 (57) | 20 (56) | 8 (57) |
- Citation: Ince V, Carr BI, Bag HG, Ersan V, Usta S, Koc C, Gonultas F, Sarici BK, Karakas S, Kutluturk K, Baskiran A, Yilmaz S. Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort study. World J Gastrointest Surg 2020; 12(12): 520-533
- URL: https://www.wjgnet.com/1948-9366/full/v12/i12/520.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i12.520